Filing Details

Accession Number:
0001123292-18-000869
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-07-19 18:03:10
Reporting Period:
2018-07-17
Accepted Time:
2018-07-19 18:03:10
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1356090 Intrexon Corp XON Services-Commercial Physical & Biological Research (8731) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1724195 Helen Sabzevari 20374 Seneca Meadows Parkway
Germantown MD 20876
President, Precigen, Inc. No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-07-17 25,000 $0.00 25,000 No 4 M Direct
Common Stock Disposition 2018-07-18 8,402 $14.54 16,598 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Restricted Stock Units Disposition 2018-07-17 25,000 $0.00 25,000 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
75,000 No 4 M Direct
Footnotes
  1. Each restricted stock unit represents a contingent right to receive one share of XON common stock.
  2. This sale was effected pursuant to the terms of a 10b5-1 plan adopted by the reporting person and was made in order to pay the tax liability arising from the vesting of restricted stock units.
  3. The restricted stock units were granted on March 28, 2018, and the remaining restricted stock units vest in three equal annual installments on each of July 17, 2019, 2020 and 2021.